JournalsHub
.online
Find My Journal
BS

Benjamin Solomon

Peter MacCallum Cancer Centre AU

ORCID 0000-0003-3059-5730
820
Publications
63,526
Citations
98
H-Index
335
i10-Index
12.66
2yr Mean Cite
-
Cite/Paper
Data combined from OpenAlex + Semantic Scholar. OA = OpenAlex S2 = Semantic Scholar
Verify on Google Scholar

Publication & Citation Trends

Publications

0 total

ALKTERNATE: A Pilot Study Alternating Lorlatinib With Crizotinib in ALK-Positive NSCLC With Prior ALK Inhibitor Resistance

M. Itchins, S. Liang, Chris Brown, Tristan Barnes, G. Marx - JTO Clinical and Research Reports, 2024
Cited by 1 Semantic Scholar

Lurbinectedin in small cell lung cancer: real‐world experience of a multicentre national early access programme

Marliese Alexander, Jennifer Rogers, S. Parakh, Paul Mitchell, T. Clay - Internal medicine journal (Print), 2024
Cited by 5 Semantic Scholar

P47.12 ALKternate: A Proof of Concept Study in ALK-Rearranged NSCLC Alternating Lorlatinib With Crizotinib After Disease Progression OA

M. Itchins, S. Liang, C. Brown, B. Solomon, N. Pavlakis - Journal of Thoracic Oncology, 2021
Cited by 0 Semantic Scholar

Lung Cancer in Australia. OA

Thomas John, Wendy A. Cooper, Gavin Wright, Shankar Siva, B. Solomon - Journal of Thoracic Oncology, 2020
Cited by 34 Semantic Scholar

Stereotactic ablative radiotherapy versus standard radiotherapy in stage 1 non-small-cell lung cancer (TROG 09.02 CHISEL): a phase 3, open-label, randomised controlled trial.

David Ball, David Ball, G. T. Mai, S. Vinod, S. Babington - The Lancet Oncology, 2019
Cited by 422 Semantic Scholar

Treatment of ALK‐rearranged non‐small cell lung cancer: A review of the landscape and approach to emerging patterns of treatment resistance in the Australian context OA

M. Itchins, M. Itchins, P. Chia, S. Hayes, S. Hayes - Asia-Pacific Journal of Clinical Oncology, 2017
Cited by 13 Semantic Scholar

Research Topics

Lung Cancer Treatments and Mutations (443) Lung Cancer Research Studies (177) Colorectal Cancer Treatments and Studies (132) Lung Cancer Diagnosis and Treatment (131) Cancer Immunotherapy and Biomarkers (130)

Affiliations

Hebron University
PS 2016 - 2016
Novartis (Switzerland)
CH 2011 - 2011
Merck & Co., Inc., Rahway, NJ, USA (United States)
US 2023 - 2023
Roche (United States)
US 2023 - 2023
Houston Methodist
US 1995 - 1995

External Profiles

OpenAlex Profile Semantic Scholar Profile ORCID Profile Google Scholar

Share Profile

Back to Researchers
Comparison Shortlist
0 journals
Est. APC Budget: $0
Compare Now